CCL Products (India) Limited has announced the resignation of a key senior management personnel, marking a significant corporate development for the coffee products manufacturer.

Senior Management Departure

Mr. Thirumala Prasad Rajanandam, Deputy General Manager - Commercial, has resigned from his position effective from the closing business hours of March 18, 2026. The resignation was formally submitted through a letter dated March 06, 2026, addressed to the Chief Human Resources Officer.

Regulatory Compliance and Disclosure

The company has fulfilled its regulatory obligations by informing both the National Stock Exchange of India Limited and BSE Limited about this corporate change. As per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30 read with Schedule III, Part A, companies must disclose changes in Senior Managerial Personnel.

The disclosure was made in accordance with SEBI Master Circular requirements, with Company Secretary & Compliance Officer Sridevi Dasari signing the intimation on March 18, 2026.

Resignation Details and Personal Statement

In his resignation letter, Mr. Rajanandam cited pressing personal commitments as the primary reason for his departure. He expressed that due to these commitments, he would not be able to devote the required attention and energy to fulfill his role effectively.

Key aspects of the resignation include:

• Notice Period: Despite a contractual notice period of 60 days, the resignation was accepted with immediate effect
• Material Reasons: The departing executive confirmed there are no material reasons beyond personal commitments
• Gratitude: Expressed appreciation for opportunities and support received during his tenure
• Organizational Well-wishes: Extended wishes for continued success to CCL Products

Corporate Communication

The formal communication was addressed to both major stock exchanges where CCL Products is listed. The company maintains its corporate office at Banjara Hills, Hyderabad, while its registered office is located in Duggirala, Guntur District, Andhra Pradesh.

This resignation represents a routine corporate governance disclosure, with the company ensuring transparency in communicating senior management changes to stakeholders and regulatory authorities.

CCL Products (India) Limited has announced the exercise of 319 equity shares under its Employee Stock Option Scheme 2022, marking another milestone in the company's employee benefit initiatives. The exercise was completed by an eligible employee on March 18, 2026, following the completion of the applicable vesting period as per the official regulatory filing.

ESOP Exercise Details

The company has provided comprehensive details regarding the stock option exercise in compliance with SEBI regulations. The shares were transferred from the CCL Employees Trust, which was established specifically for implementing the employee stock option scheme.

Share Capital Impact

The company has clarified that this exercise does not result in any change to its paid-up share capital. The allotted shares will rank pari-passu with the existing shares of the company, ensuring equal rights and privileges for all shareholders.

Regulatory Compliance

The disclosure has been made pursuant to Regulation 10 of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company has filed the necessary documentation with both NSE and BSE, maintaining transparency with the stock exchanges.

Key compliance aspects include:

• Shares issued in demat form with no physical certificates
• No lock-in period applicable to the exercised shares
• Shares identical in all respects to existing equity shares
• No additional listing fees payable

Scheme Background

The CCL Employee Stock Option Scheme 2022 was previously filed with the stock exchanges in two tranches. The initial filing for 4,00,000 shares was completed in September 2022, followed by an additional filing for 1,00,000 shares in February 2024.

This systematic approach demonstrates the company's commitment to structured employee benefit programs and regulatory compliance. The shares are listed on both National Stock Exchange of India Limited and BSE Limited, with scrip codes CCL and 519600 respectively.